TFF Group (OTCMKTS:FRFTF) Sees Significant Drop in Short Interest

TFF Group (OTCMKTS:FRFTF) was the recipient of a significant decline in short interest in February. As of February 27th, there was short interest totaling 15,206 shares, a decline of 17.1% from the February 12th total of 18,343 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

TFF Group Stock Performance

Shares of TFF Group stock opened at C$20.14 on Monday. TFF Group has a 1 year low of C$20.14 and a 1 year high of C$20.70. The business has a 50-day moving average of C$20.31 and a two-hundred day moving average of C$21.34.

TFF Group Company Profile

TFF Group (OTCMKTS:FRFTF) is a clinical-stage specialty pharmaceutical company developing and commercializing medicines based on its proprietary thin-film drug delivery platform. The company’s core technology transforms active pharmaceutical ingredients into solid films that dissolve rapidly in the oral cavity or adhere to mucosal surfaces, enabling precise dosing without water, potential improvements in bioavailability and the opportunity to create novel dosage forms. TFF Group’s platform supports a broad range of molecules, from small-molecule drugs and peptides to vaccines and biologics.

Headquartered in Kansas City, Missouri, with research and manufacturing facilities in Europe, TFF Group applies its thin-film technology across multiple therapeutic areas, including central nervous system disorders, hormone replacement therapy, respiratory diseases and vaccines.